Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.

NCT02970669 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Reduced Ejection Fraction

Interventions

DRUG: sacubitril/valsartan (LCZ696)
DRUG: enalapril
DRUG: matching placebo sacubitril/valsartan (LCZ696)
DRUG: matching placebo enalapril

Sponsor

Novartis Pharmaceuticals